Company That Raised Price of Epipens 1000 Percent Is Clinton Foundation Donor


Epipens are a lifesaving device that many people with allergies need to carry at all times in case of an emergency but recently the price of these items has skyrocketed. Would you believe a Clinton Foundation donor is behind the price gouging?

The Daily Caller reports:

Company Gouging Price Of EpiPens Is A Clinton Foundation Donor And Partner

The pharmaceutical company that distributes the EpiPen is also a Clinton Foundation donor.

Hillary Clinton criticized the company, Mylan, on Wednesday, calling its price hikes of the life-saving medical device “outrageous.”

“It’s just the latest troubling example of a company taking advantage of its consumers,” said Clinton.

But those remarks highlight Clinton’s radio silence on the price of the EpiPen, which has grown steadily since 2007, when Mylan acquired rights to sell the 50-year-old drug.

EpiPen injections, which help stop potentially fatal allergic reactions, cost $57 in 2007. They now run $609. According to CNBC, the price of EpiPens has increased at a steady rate in those nine years.

As of May 2011, the price was $165. That rose to $350 in 2014 and $461 last year.

The Clinton Foundation partnered with Mylan at a time when it was raising prices on the EpiPen, which had been distributed by Merck.

Ironically, the company partnered in 2009 with the Clinton Foundation to provide a lower-cost alternative for four HIV drugs. Clinton Foundation records show that Mylan has donated between $100,000 and $250,000 to the Foundation. It is not clear when the donation was made, but it likely corresponded with the 2009 partnership.

According to a Clinton Foundation press release, Mylan pledged to offer the drugs for $425 per year by 2010. The cost was 28 percent lower than competing drugs, according to the Clinton Foundation.

Are you as shocked as we are?


To Top